Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Dysphagia
Erschienen in: Dysphagia 2/2023

18.05.2022 | Review

Update on the Diagnosis and Treatment of Achalasia

verfasst von: Wojciech Blonski, Samuel Slone, Joel E. Richter

Erschienen in: Dysphagia | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Achalasia is a rare disease of the esophagus with impaired relaxation of the lower esophageal sphincter and aperistalsis. The etiology is unknown but speculations include a viral or autoimmune etiology. All specialists dealing with swallowing and esophageal diseases should recognize the classic symptoms of dysphagia for solids/liquids, regurgitation, and choking, especially at night. High-resolution manometry is critical for the diagnosis with endoscopy and barium esophagram having a supportive role. The disease cannot be cured but most can return to near normal swallowing and a regular diet with appropriate therapy. Treatment includes smooth muscle relaxants, botulinum toxin injections to the lower sphincter, pneumatic dilation, Heller myotomy, and peroral endoscopic myotomy. One treatment does not fit all and a tailored approach through a multidiscipline team will give the best long-term outcomes.
Literatur
1.
Boeckxstaens GE, Zanitto G, Richter JE. Achaslasia. Lancet. 2014;383:89–93.CrossRef
2.
Samo S, Carlsen DA, Gregory DL, et al. Incidence and prevalence of achalasia in central Chicago, 2004–2014, since widespread use of high resolution manometry. Clin Gastroenterol Hepatol. 2017;15:366–73.PubMedCrossRef
3.
Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–14.PubMedCrossRef
4.
Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23(11):724–8.PubMedCrossRef
5.
Aggestrup S, Uddman R, Jensen SL, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept. 1985;10(2–3):167–78.PubMedCrossRef
6.
Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981;80(2):327–33.PubMedCrossRef
7.
de Oliveira RB, RezendeFilho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90(7):1119–24.PubMed
8.
Sodikoff JB, Lo AA, Shetuni BB, Kahrilas PJ, Yang GY, Pandolfino JE. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28(1):139–45.PubMedCrossRef
9.
Jones DB, Mayberry JF, Rhodes J, Munro J. Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983;36(6):655–7.PubMedPubMedCentralCrossRef
10.
Naik RD, Vaezi MF, Gerskon AA et al. Association of achalasia with active varicella zoster infection of the esophagus. Gastroenterol 2021
11.
Furuzawa-Carballeda J, Aguilar-Leon D, Gamboa-Dominguez A, et al. Achalasia–an autoimmune inflammatory disease: a cross-sectional study. J Immunol Res. 2015;2015:729217.PubMedPubMedCentralCrossRef
12.
Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci. 1989;34(3):349–52.PubMedCrossRef
13.
De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998;52(4):381–4.PubMedCrossRef
14.
Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999;117(1):26–31.PubMedCrossRef
15.
Gockel I, Becker J, Wouters MM, et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet. 2014;46(8):901–4.PubMedCrossRef
16.
Booy JD, Takata J, Tomlinson G, Urbach DR. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus. 2012;25(3):209–13.PubMedCrossRef
17.
Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002;47(1):15–9.PubMedCrossRef
18.
King D, Thomas T, Chandan JS, et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol. 2021;116(2):416–9.PubMedCrossRef
19.
20.
21.
Eckardt V, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.PubMedCrossRef
22.
Urbach DR, Tomlinson G, Harnish JG. A measure of disease-specific health related quality of life for achalasia. Am J Gastroenterol. 2005;100:1668–76.PubMedCrossRef
23.
Slone S, Kumar A, Jacobs J, Velanovich V. Richter JE. Accuracy of achalasia quality of life and Eckardt scores for assessment of clinical improvement post treatment for achalasia. Dis Esophagus 2020 https://​doi.​org/​10.​1092/​doaa080
24.
ASGE Standards and Practice Committee, Patria SF, Acosta R, et al. The role of endoscopy in the evaluation and management of achalasia. Gastrointestinal Endosc. 2014;79:191–201.CrossRef
25.
Levine MS, Rubesin SE, Laufler IL. Barium studies in modern radiology. Do they have a role? Radiology. 2009;250:18–22.PubMedCrossRef
26.
Howard PJ, Maker G, Pryde A, et al. Five year prospective study of the incidence, clinical features and diagnosis of achalasia in Edinburg. Gut. 1992;33:1011–5.PubMedPubMedCentralCrossRef
27.
Slone S. Kumar A, Richter JE. Community approach to the diagnosis of achalasia: High resolution manometry is helping but needs to be earlier than later. DDW 2021.
28.
Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21(8):796–806.PubMedPubMedCentralCrossRef
29.
Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.PubMedPubMedCentralCrossRef
30.
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.PubMedCrossRef
31.
Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021;33(1):e14058.PubMedPubMedCentralCrossRef
32.
Chavez YH, Ciarleglio MM, Clarke JO, et al. Upper esophageal abnormalities. Frequent finding on high resolution esophageal manometry and associated with poorer treatment response in achalasia. J Clin Gastroenterol. 2015;49:17–23.PubMedCrossRef
33.
Yoneyama F, Miyacki M, Nimura Y. Manometric findings of the upper esophageal sphincter in esophageal achalasia. World J Surg. 1998;22:1043–6.PubMedCrossRef
34.
Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hepatol. 2011;9(12):1010–1.PubMedCrossRef
35.
de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997;169(2):473–9.PubMedCrossRef
36.
Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.PubMedCrossRef
37.
Zaninotto G, Bennett C, Boeckxstaens G, et al. the 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31:1–29.CrossRef
38.
Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–70.PubMedPubMedCentralCrossRef
39.
Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow for assessing long-term treatment response in patients with achalasia: Absolute cutoff versus percent change - A cross-sectional analytic study. Neurogastroenterol Motil 2020:e14005.
40.
Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–35.PubMedCrossRef
41.
Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedPubMedCentralCrossRef
42.
Carlson DA, Lin Z, Rogers MC, Lin CY, Kahrilas PJ, Pandolfino JE. Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study. Neurogastroenterol Motil. 2015;27(7):981–9.PubMedPubMedCentralCrossRef
43.
Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.PubMedPubMedCentralCrossRef
44.
Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil 2017;29(1).
45.
46.
Wen ZH, Gardner E, Wang YP. Nitrates for achalasia. Cochrane database of systematic reviews. 2004; CD002299
47.
Prakash C, Freeland KE, Chan ME, Clause RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94:328–33.PubMedCrossRef
48.
Renske AB, Nijhuis O, Prius LT, et al. Factors associated with achalasia treatments outcomes: systematic review and meta-analysis. Clinical Gastroenterol Hepatol. 2021;18:1442–53.
49.
Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical guidelines: diagnosis and management of Achalasia. Am J Gastroenterol. 2020;115(9):1393–411.PubMedPubMedCentralCrossRef
50.
Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.PubMedCrossRef
51.
Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008;2(3):435–45.PubMedCrossRef
52.
53.
Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45(5):349–53.PubMedCrossRef
54.
Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004;99(12):2304–10.PubMedCrossRef
55.
Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–5.PubMedCrossRef
56.
Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.PubMedCrossRef
57.
Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013;144(4):718–725; quiz e713–714.
58.
Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.PubMedCrossRef
59.
Br O, Chang L, Pelligrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surgery. 2003;138:490–5.CrossRef
60.
Richards WO, Torquari A, Holtzman MD, et al. Heller myotomy vs Heller myotomy and Dor fundoplication for achalasia: a prospective randomized double blind study. Ann Surg. 2004;240:405–12.PubMedPubMedCentralCrossRef
61.
Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57.PubMedCrossRef
62.
Werner Y, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–29.PubMedCrossRef
63.
Li J, Lieb J, Gianos JM, et al. Reasons and prevalence of reoperations after esophagomyotomy for achalasia. Surg Laprosc Endo Percutan Tech. 2012;22:392–5.
64.
Guo JP, Gilman PB, Thomas RM, et al. Barrett’s esophagus and achalasia. J Clin Gastroenterol. 2002;34:439–43.PubMedCrossRef
65.
Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.PubMedCrossRef
66.
Stavropoulos SN, Friedel D, Modayil R, Iqbal S, Grendell JH. Endoscopic approaches to treatment of achalasia. Therap Adv Gastroenterol. 2013;6(2):115–35.PubMedPubMedCentralCrossRef
67.
Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology. 2017;153(5):1205–11.PubMedCrossRef
68.
Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–76.PubMedCrossRef
69.
Patel KS, Calixte R, Modayil RJ, Friedel D, Brathwaite CE, Stavropoulos SN. The light at the end of the tunnel: a single-operator learning curve analysis for per oral endoscopic myotomy. Gastrointest Endosc. 2015;81(5):1181–7.PubMedCrossRef
70.
Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol 2018;16(9):1420–1426 e1422.
71.
Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–44.PubMedPubMedCentralCrossRef
72.
Andolfi C, Fisichella PM. Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes. Br J Surg. 2019;106(4):332–41.PubMedCrossRef
73.
Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018;87(4):934–943 e918.
74.
Ichkhanian Y, Benias P, Khashab MA. Case of early Barrett cancer following peroral endoscopic myotomy. Gut. 2019;68(12):2107–10.PubMedCrossRef
75.
Ratuapli SK, Crowell MD, Dibuse JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.PubMedCrossRef
76.
Babari A, Szabo A, Shad S, et al. Chronic daily opioid exposure is associated with dysphagia, EGJ outflow obstruction and disordered perstalsis. Neurogastroenterol Motil. 2019;31:e13601.
77.
Ortiz V, Garcia-Campo M, Saez-Gonzales E, et al. A concise review of opioid-induced esophageal dysfunction: Is this a new clinical entity? Dis Esophagus. 2018;31:1–6.CrossRef
78.
Snyder DL, Crowell MD, Horsley-Silva J, et al. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.PubMedCrossRef
79.
Richter JE. Tailoring therapy for achalasia. Gastroenterol and Hepatol. 2020;16:249–56.
80.
Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: pancea, placebo or pathway to the future. Gastroenterol Hepatol. 2008;5:283–95.
81.
Jacobs J, Richter JE. Opening the bird’s beak: tips and tricks for effective pneumatic dilation for achalasia. Am J Gastroenterol. 2016;111(2):157–8.PubMedCrossRef
Metadaten
Titel
Update on the Diagnosis and Treatment of Achalasia
verfasst von
Wojciech Blonski
Samuel Slone
Joel E. Richter
Publikationsdatum
18.05.2022
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 2/2023
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10435-3

Weitere Artikel der Ausgabe 2/2023

Dysphagia 2/2023 Zur Ausgabe

Original Article

Functional Laryngeal Assessment in Patients with Tracheostomy Following COVID-19 a Prospective Cohort Study

Original Article

Heterotopic Gastric Mucosa in the Proximal Esophagus: Prospective Study and Systematic Review on Relationships with Endoscopic Findings and Clinical Data

Review

A Short History of High-Resolution Esophageal Manometry

Review

A Tutorial on Diagnostic Benefit and Radiation Risk in Videofluoroscopic Swallowing Studies

Retraction Note

Retraction Note: Neuromuscular Specializations of the Human Hypopharyngeal Muscles

Original Article

Endoscopic Stricturotomy in the Treatment of Refractory Esophageal Anastomotic Strictures

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise